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Abstract
Graphical models describe the linear correlation structure of data and have been used to establish causal relationships
among phenotypes in genetic mapping populations. Data are typically collected at a single point in time. Biological
processes on the other hand are often non-linear and display time varying dynamics. The extent to which graphical models
can recapitulate the architecture of an underlying biological processes is not well understood. We consider metabolic
networks with known stoichiometry to address the fundamental question: ‘‘What can causal networks tell us about metabolic
pathways?’’. Using data from an Arabidopsis Bay|Sha population and simulated data from dynamic models of pathway
motifs, we assess our ability to reconstruct metabolic pathways using graphical models. Our results highlight the necessity
of non-genetic residual biological variation for reliable inference. Recovery of the ordering within a pathway is possible, but
should not be expected. Causal inference is sensitive to subtle patterns in the correlation structure that may be driven by a
variety of factors, which may not emphasize the substrate-product relationship. We illustrate the effects of metabolic
pathway architecture, epistasis and stochastic variation on correlation structure and graphical model-derived networks. We
conclude that graphical models should be interpreted cautiously, especially if the implied causal relationships are to be
used in the design of intervention strategies.
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Introduction
Understanding the nature of cause and effect is fundamental to
all fields of scientific investigation, but the concept of causality can
present special difficulties in biology [1]. Experiments that utilize
controlled interventions represent the most widely used approach
to establishing causality. However, in his seminal work on
experimental design, RA Fisher proposed that causation can be
inferred from multi-factorial experiments performed with ran-
domization [2]. An extension of this principle provides the
foundation for computational approaches to network reconstruc-
tion in experimental genetic crosses, such as the recombinant
inbred strain panel used in this study. Natural allelic variation is
randomized during meiosis to generate a multi-factorial pertur-
bation affecting multiple phenotypic outcomes. This meiotic
randomization allows for the inference of quantitative trait loci
(QTL) that are causal to phenotype [3].
Recent advances in high-throughput phenotyping technologies
have made large-scale measurements of molecular traits possible.
Expression QTL (eQTL), metabolic QTL (mQTL) and protein
QTL (pQTL) can be used to link thousands of molecular
phenotypes to genetic loci, as well as to clinical phenotypes [4].
A typical xQTL study will involve cross sectional sampling of a
genetically variable population at a single time point. It is not
immediately obvious that such data could provide insight into
causal biological mechanisms, which derive from non-linear
dynamic processes of gene expression and metabolism. However,
a rich body of literature supports the idea that correlation structure
in static data can provide insights into causal relationships among
the measured variables [5,6].
The interpretation of a directed edge between nodes A and B in
a graphical model is that intervention on A will alter B, but
intervention on B will not alter A. In a metabolic reaction,
intervention on the substrate concentration will alter the product
concentration. Reaction stoichiometry is often well understood
[7]. Substrate molecules are converted by known enzymes into
products, which in turn act as substrates for subsequent reactions.
Reactions are organized into pathways which may converge,
branch or intersect to form elaborate networks. More complex
pathways involving feedback through allosteric interactions
between enzymes and metabolites may also be present. It is not
clear to what extent graphical models inferred from mQTL data
capture these types of interactions.
Several algorithms have been proposed for the inference of
causal relationships among phenotypes using genetic data [8–14].
These methods employ linear statistical models to infer the
relationships between QTL and phenotypes, as well as relation-
ships among phenotypes [15]. Causal edge detection is sensitive to
subtle correlation patterns in the data. Inferences have been shown
to be subject to a large proportion of false positive edges and can
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be skewed by environmental and experimental design factors that
are not accounted for in the model [16,17]. Agreement between
the graphical model and the true underlying biology is a central
goal of systems biology. The topology of networks inferred from
xQTL data is often interpreted as a reflection of the underlying
biological process - which may be metabolic or regulatory in
nature, nonlinear, and involve the dynamic interaction of
molecules within cells and tissues. However, the extent to which
graphical models derived from static data capture these processes
is not well understood, which makes the interpretation of edges
challenging.
Deterministic models of cellular metabolism can be defined by
ordinary differential equations (ODEs) derived from simple laws of
mass-balance [18–21]. The reaction rates are modeled as non-
linear processes, e.g. Michaelis-Menten kinetics and Hill functions,
which depend on kinetic rate parameters [22]. Models of this type
are powerful because of their ability to make in silico predictions of
the response of a system to perturbations. We present a simulation
study in which we generate synthetic mQTL data from dynamical
models of pathway motifs with two sources of perturbation. We
vary the rate parameters in a manner that mimics a genetic cross
and we drive the simulations models with an input function that
includes stochastic noise.
Glucosinolates are secondary metabolites that influence the
interaction of plant and pest and have a wide range of important
functions in human health [23–25]. The economic importance of
glucosinolates has led to significant progress in understanding the
biochemical pathways and genetics [26,27]. Glucosinolate biosyn-
thesis occurs in three well understood stages in which amino acids
undergo (Figure 1): (1) chain-elongation, (2) formation of glucone
moeity, and (3) side-chain modification. In this work, we examine
mQTL data from a class of aliphatic glucosinolates in a highly
replicated Arabidopsis Bay|Sha recombinant inbred population
[28]. The metabolites under investigation participate in side-chain
reactions. Genetic analysis reveals shared QTL and wide-spread
epistasis in the pathway [29].
In order to address these questions, we have inferred causal
networks from mQTL data using simulated metabolic models of
common pathway motifs and real data from a well characterized
metabolic network. We demonstrate that correlation structure can
be shaped by a variety of factors, including, genetic variation,
pathway architecture, position in the pathway and feedback. Our
results highlight the necessity of biological variation outside of the
variation contributed by genetic factors for reliable network
inference. Substrate-product relationships are not always reflected
in the correlation structure of the system and recovery of the
biochemical ordering of species should not be expected. Substrate
inhibition, which is pervasive in metabolic pathways, can diminish
or mask these relationships and lead to missing edges in network
inference. An accurate genetic model is also critical to the
inference process, especially when epistasis is involved. Our
findings should temper expectations and provide new insights
into the interpretation of causal genotype-phenotype networks.
Results
Pathway motifs were constructed using ODEs (Figure 2). Flux
rates, w, were described with Michaelis-Menton kinetics.
Simulations were performed under genetic perturbations, y,
with stochastic input, j(t) (Figure S1). The aliphatic glucosinolate
biosynthetic pathway from an Arabidopsis Bay|Sha population
was also investigated (Figure 1). For each pathway, we carried out
a three-step analysis: (1) QTL mapping for the metabolites in the
pathway to identify the relevant genetic factors. (2) Metabolite
correlations were calculated with and without conditioning on
genetic factors. Correlation after conditioning represents the
association between metabolites that is driven by sources outside
of the genetic factors, e.g., propogation of random input
fluctuations through the pathway. Correlation that disappears
after conditioning implies an independent relationship between
metabolites, e.g., Q?M1 and Q?M2. We interpret the presence
of correlation after conditioning as being indicative of either
causal or reactive relationships, e.g., Q?M1?M2 or
Q?M2?M1. (3) We generated multiple causal networks from
their posterior distribution, using a MCMC algorithm previously
described [14] and summarized results across the ten top scoring
networks.
Simulated Pathway Motifs
QTL detection. Correlation of the genotype variable, y, and
a metabolite is considered evidence for a QTL with the sign and
magnitude indicating the direction of the effect and the effect size
(Figure 3). A similar QTL pattern is observed between pathways
that contain linear chains of reactions. Specifically, the QTL for a
substrate metabolite in a linear chain is the y facilitating the
downstream flux (e.g., Figure 3A). In the merging pathway via
metabolic reaction; there are no QTL for the bi-substrate reaction
that occurs at the merge point (Figure 3B). However, when the
merging pathway is formed through two independent paths QTL
mimic the linear pathway pattern (Figure 3C). The QTL effect
pattern in the branching pathway illustrates the activation of the
lower and upper branch (Figure 3C). When the flux through the
upper branch is dominant, the production of C is demanding
substrate B, which is then less available for the production of D.
This scenario is reflected in positive correlation between y2 and C,
and the negative correlation between y2 and D and B. An
analogous story plays out for the lower branch and is seen in the
y4 relationships. Substrate inhibition in the branching pathway
results in the loss of QTL at y2 which facilitates the inhibited flux
(Figure 3E). In the branching pathway with epistasis, y2 is a QTL for
the branch-point metabolite B, and both C and D which reside on
the branches (Figure 3F). The direction of the effect is a reflection
of the metabolite position in the pathway. Epistasis has the
strongest effects on A and C which are immediately downstream
of the interacting signal and enzyme respectively.
Author Summary
High-throughput profiling data are pervasive in modern
genetic studies. The large-scale nature of the data can
make interpretation challenging. Methods that estimate
networks or graphs have become popular tools for
proposing causal relationships among traits. However, it
is not obvious that these methods are able to capture
causal biological mechanisms. Here we address the power
and limitations of causal inference methods in biological
systems. We examine metabolic data from simulation and
from a well-characterized metabolic pathway in plants. We
show that variation has to propagate through the pathway
for reliable network inference. While it is possible for causal
inference methods to recover the ordering of the
biological pathway, it should not be expected. Causal
relationships create subtle patterns in correlation, which
may be dominated by other biological factors that do not
reflect the ordering of the underlying pathway. Our results
shape expectations about these methods and explain
some of the successes and failures of causal graphical
models for network inference.
What Can Causal Networks Tell Us about Pathways?
PLoS Computational Biology | www.ploscompbiol.org 2 April 2012 | Volume 8 | Issue 4 | e1002458
Metabolite correlations. In most cases, the correlation
between metabolites after conditioning on genotype variables
was enhanced (Figure 3). Substrates in the linear pathway are
uniformly correlated both before and after conditioning on QTL
(Figure 3A). In the merging pathway via metabolic reaction, a high
correlation between A and B suggests that they must be
coordinated to form a product C (Figure 3B). In the merging
pathway via independent paths A and B are uncorrelated, C and D are
highly correlated to each other, and to a lesser degree with A and
B (Figure 3C). In the branching pathway A and B are highly
correlated and relationships involving C and D become more
pronounced after conditioning (Figure 3D). Substrate inhibition is
observed in the negative correlation of D with the other
metabolites in the pathway (Figure 3E). The correlation in this
pathway was the most sensitive to conditioning on QTL. After
conditioning there was almost a total loss of correlation between B
and metabolites on the upper branch, C and D (Figure 3E). In the
branching pathway with epistasis, B and C are negatively correlated
reflecting the accumulation of B when there is an allelic
combination that results in the loss of function of w2 (Figure 3F).
The strongest correlation is between B and D.
Network reconstructions. The linear and merging pathway
reconstructions did not mimic the ordering in the metabolic
pathway (Figure 3A–C). A causal edge A?C occurred in the linear
pathway in the ten best scoring models (Figure 3A), but faded when
larger subsets of models were considered (Text S1). In the merging
pathway via metabolic reaction a causal edge A?B and an undirected
edge between C and D were identified, with no link between the
two pathway segments (Figure 3B). When A and B form C from
merging independent pathways, C is predicted as a hub metabolite that
affects both upstream and downstream neighbors. It is reasonable
that C, the merging point, controls the influx and efflux of the
pathway and dominates the overall correlation structure
(Figure 3C). The graphical model for the branching pathway
captures the biochemistry exactly but does not include the
genetic factors (Figure 3D). When substrate inhibition occurs in the
branching pathway, the graphical model identifies the top and
bottom branches, but does not link them together (Figure 3E). In
the network reconstruction of the branching pathway with epistasis, the
lower branch of the pathway is captured exactly and the epistasis
term was found to affect B and C independently (Figure 3F).
Bay|Sha: Aliphatic Glucosinolate Biosynthesis
QTL detection. Significant QTL were identified for all of the
metabolites in the aliphatic glucosinolate biosynthesis pathway
(Figure 4, Tables S1, S2). Common QTL on Chr4 and Chr5 with
large effects were detected for most of the metabolites. Two-
dimensional genome scans showed a significant epistatic
interaction between these two loci, especially in the homo-
methionine and dihomo-methionine side chains (Table S3, Figure
S2). MT3 showed evidence of two interacting QTL on
Chromosome 5. These results are consistent with previous
findings [28]. AOP2/3 and MAM1/3 are candidate genes
under the QTL peaks on Chr4 and Chr5 respectively [28].
Metabolite correlations. Correlation dissipated non-
uniformly after conditioning metabolites on QTL (Figure 5). In
the homo-methionine pathway, after conditioning, MT3 and Allyl
are positively correlated (r~0:41), Allyl and OHP3 have a strong
negative correlation (r~{0:67), and the correlation between
MT3 and Allyl is positive and weaker (r~0:12). After
Figure 1. Biosynthesis of aliphatic glucosinolates. The aliphatic glucosinolate biosynthetic pathway occurs in three stages: (1) side chain
elongation, (2) formation of glucone moeity and (3) side-chain modification. The metabolites that are measured in the Bay|Sha RIL population are
indicated together with the facilitating enzymes.
doi:10.1371/journal.pcbi.1002458.g001
What Can Causal Networks Tell Us about Pathways?
PLoS Computational Biology | www.ploscompbiol.org 3 April 2012 | Volume 8 | Issue 4 | e1002458
conditioning in the dihomo-methionine pathway, MT4 and
MSO4 are highly correlated (r~0:83), and But-3-enyl is
negatively correlated with both Mtb4 and MSO4 (r~{0:35
and r~{0:53 respectively). In the hexahomo-methionine
pathway, MT8 and MSO8 are highly correlated (r~0:76) after
conditioning. The most profound loss of correlation after
conditioning was observed between MT4 and MSO4 and the
other metabolites in the pathway with the exception of OHP3.
The dramatic reduction indicates that much of the correlation
between metabolites is due to shared genetic effects and is not a
result of biochemical pathway linkages, consistent with what we
know about these pathways.
Network reconstructions. Side chains: homo-methionine,
dihomo-methionine and hexahomo-methionine, were first
examined independently (Figure 6A–C). In the homo-
methionine reconstruction, the dominant allele at the QTL
directly affects Allyl and MT3, and indirectly affects OHP3
through the other metabolites. The order of metabolites in the
dihomo-methionine pathway network reconstruction matched the
biochemical pathway exactly (Figure 6B). QTL were estimated to
directly affect MT4 and But-3-enyl. The hexahomo-methionine
chain shows little evidence of epistasis, thus the interaction terms
were omitted from the analysis (Figure S2). MT8 and MSO8 were
highly correlated, and both have QTL on Chr 4 and 5 with similar
effect sizes (Figures 4–5). The graphical model is dense and
identifies a connection between MT8 and MSO8, but the
direction of causality is not clear (Figure 6C).
The entire panel of QTL and metabolites from the glucosino-
late biosynthesis pathway were examined in a single model
(Figure 6D). The graphical model groups the top half (homo-
methionine and dihomo-methionine side chains) and the lower
half (pentahomo-methionine and hexahomo-methionine side-
chains). Within these groupings, the side chain members are
connected, but the order does not match the biochemical pathway
ordering. There is a spurious connection between But-3-enyl and
Allyl. Although pathway members grouped together, the direction
of causality did not reflect the biological pathway or the ordering
inferred for the independent side-chains.
Propagation of Residual Variance
In order to infer a causal relationship between a substrate M1
and its product M2, non-genetic variation in substrate concentra-
tion has to propagate to the product. This is a necessary, but not
sufficient condition for causal inference. To see this, suppose that
one metabolite is causal to another, and that variation includes a
genetic driver, Q?M1?M2. The linear equations for the causal
graphical model can be written as:
M1~b0zb1QzE1
M2~c0zc1M1zE2,
Figure 2. Simulated pathway motifs. (A) Linear, (B) merging pathway via metabolic reaction, (C) merging pathway via independent paths, (D)
branching pathway, (E) branching pathway with inhibition, (F) branching pathway with epistasis. Apool represents a constant pool of metabolite A
taken up at a constant flux rate k that is subject to a stochastic perturbation j(t), w represents the flux rate, y is a genetic perturbation and yS
denotes an upstream signal that is affecting the pathway.
doi:10.1371/journal.pcbi.1002458.g002
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or equivalently:
M1~b0zb1QzE1
M2~c0zc1(b0zb1QzE1)zE2:
Suppose there is no propagation of the non-genetic variation, E1,
then:
M1~b0zb1QzE1
~M2~c0zc1(b0zb1Q)zE2,
and the traits are conditionally independent given genotype,
(M1\ ~M2)DQ. It is clear from the equations that, c1E1 is the term
that carries the residual correlation between M1 and M2.
Therefore, variation in metabolites beyond that induced by
genotype must be propagated through the biological pathway to
create the correlation structure necessary for causal inference.
Consider the Bay|Sha data example: Q?MT4?MSO4,
where Q denotes the QTL on Chrs 4, 5 and their interaction.
There is a strong correlation between the residuals MT4DQ and
MSO4 (r~{0:80) (Figure 7A), which is driven by the
propagation of the non-genetic variation, E1. To see this
dependency, we imputed data with no propagation of variation:
MT4~b0zb1QzE1
M~SO4~c0zc1(b0zb1Q)zE2:
Figure 3. Simulation results. Left: The correlation between metabolites and genetic multipliers, correlation indicates evidence of a QTL, the sign
and magnitude indicate direction and size of the effect respectively. Center: metabolite correlation after conditioning on QTL. Right: The inferred
causal graphical model estimated from the top ten graphs from MCMC. Edge weights indicate regression coefficients.
doi:10.1371/journal.pcbi.1002458.g003
Figure 4. Genome scans for the aliphatic metabolites. QTL mapping was performed for metabolites in the homo-methionine, dihomo-
methionine and penta/hexa-methionine side-chains from the Bay|Sha RIL population.
doi:10.1371/journal.pcbi.1002458.g004
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MT4 and M~SO4 are approximately independent with negligible
correlation (r~0:09). A causal edge between MT4 and MSO4
would not be detected with network inference (Figure 7B).
Discussion
Graphical models provide a framework for estimating causal
relationships between genotypes and phenotypes. Models of this
type can be used to perform in silico experiments that predict
responses to genetic and environmental perturbations. Ideally,
these models should inform us about of the response to targeted
interventions, such as a drug that alters the properties of a
metabolic enzyme. There are numerous reasons for caution in
such inferences. The inference models are linear, but the true
relationships among relevant variables is likely to be driven by a
non-linear dynamical process. It is not clear that these relation-
ships should be captured by linear correlation. Correct interpre-
tation is important, particularly if the graphical models are used to
guide intervention strategies.
Several algorithms have been proposed for building graphical
models in the context of genetic crosses [8–14]. These methods all
derive models from the correlation and partial correlation
structure in the data. We found that the available model building
methods produced highly concordant results for models of the size
and architectures considered here. Therefore we chose one specific
MCMC algorithm to investigate the relationship between an
inferred graphical model and the biochemical pathway that gave
rise to the data. An advantage of the MCMC algorithm is the
ability to sample multiple networks from a posterior distribution.
This avoids reliance on a single network, which is problematic
when two or more distinct networks can explain the data equally
well. Sampling also provides a measure of uncertainty in the
inferred network topology. Summarizing an ensemble of networks
is challenging. We chose a consensus representation consisting of
edges that occur most frequently in the sampled networks. If there
is not enough information in the data to reliably establish the
existence of an edge, this is reflected in low edge weights of the
consensus network. Also, if we observe an edge that is present in
most of the sampled networks but with opposing directions in
different networks, we can conclude that the edge is present but
there is insufficient data to resolve it direction (e.g., Figure 6C).
We analyzed metabolite data and from real and simulated
pathways with known network stoichiometry. The Michaelis-
Menton kinetics used in our simulated metabolic reactions are
special cases of Hill functions and represent a rough approxima-
tion to actual enzyme reactions. Similar models have been used to
describe gene regulatory networks and other biological phenom-
ena, e.g. [19,20,30]. Constraint based modeling provide an
alternative approach to delineate metabolic networks from
steady-state data [31]. In the steady-state, the system of ODEs
reduces to a linear system, but nonlinear relationships may arise
between fluxes and pathways [32]. Investigation of the properties
of constraint based and other non-correlation based methods for
inference in dynamical systems remains an area of active research
[33–36].
Correlation in metabolite data can be driven by a variety of
factors that do not directly relate to the network stoichiometry. In
order to capture the biochemical ordering of the pathway, noise
has to propagate through the biochemical network. Many
biological pathways are buffered by feedback or other stabilizing
features that reduce noise propagation and mask the correlations
that would imply causal connections. Failure to consistently
observe substrate-product correlation may explain some of the
differences observed between the plant data and simulations for
matching pathway architectures. Our objective is not to confirm
that our simulations accurately reflect the plant data or to make
generalizations about certain pathway architectures. Rather, we
seek to leverage real data from a well-studied biological system and
simulated data from pathway motifs to explore a variety of
architectures and conditions. A shortcoming of in silico models is
Figure 5. Aliphatic metabolite correlations. Correlation of metabolites in from the Bay|Sha RIL population with (A) no conditioning on QTL
and (B) after conditioning on QTL.
doi:10.1371/journal.pcbi.1002458.g005
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their inability to fully capture the richly interconnected nature of
biological systems. We considered simple motifs in isolation and
modeled them with Michaelis-Menton kinetics. Correlation
structure depends on the network architecture, the size and
nature of the genetic perturbation, stochastic fluctuation, and
enzyme kinetics. The advantage of this simulation is that no
biological variation arises from factors outside of what is modeled.
Whereas, metabolic systems in vivo contain mechanisms that make
them robust, e.g., buffering, cycling and feedback, but may be
impossible to pin-point with real data.
In the plant data, many of the substrate-product relationships
remain intact after conditioning on QTL (Figure 5). This suggests
that a real metabolic pathway may give rise to meaningful
biological correlations that reflect the topology of the pathway
despite the non-linear nature of the underlying processes. This is
promising from the point of view of network reconstruction, but is
not without limitation. The architecture of the homo-methionine
side-chain was only partially captured, with an additional edge
between Allyl and OHP3 that reflects the shunting of flux through
the lower branch of the pathway (Figure 6A). The biochemical
ordering of the dihomo-methionine side-chain was captured
exactly (Figure 6B). We are only to able to detect an undirected
connection between MT8 and MSO8 in the hexahomo-methio-
nine side-chain (Figure 6C). Lack of a private QTL or a gradient
in the effect size gives rise to likelihood equivalent models from
which the direction of causality could not be distinguished. A
similar situation was observed when a global model was estimated
from the entire panel of metabolites and QTL (Figure 6D). The
shared nature of the QTL hindered network reconstruction of the
entire pathway. Most of the side-chain members were linked, but
the direction of causality was not consistent with the pathway or
with the networks constructed for each of the side-chains
independently. Allyl and But-3-enyl are unlinked in the metabolic
pathway, but are both products in reactions facilitated by AOP2.
The causal link between them is likely driven by this co-regulation.
Conditioning on QTL genotypes strengthens the correlation
among metabolites in most of the simulated pathway motifs
(Figure 3). An exception occurs in the branching pathway with
Figure 6. Aliphatic glucosinolate network reconstructions. The (A) homo-methionine, (B) dihomo-methioine and (C) hexahomo-methionine
side chains were reconstructed independently. (D) The network was reconstructed from the entire panel of aliphatic metabolites and their QTL. Edge
weights indicate regression coefficients.
doi:10.1371/journal.pcbi.1002458.g006
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substrate inhibition which shows an almost complete loss of
correlation between the branchpoint B and upper branch
metabolites C and D after conditioning (Figure 3F). In the linear
pathway, when reaction rates are not operating at saturation and
there are no branches to redirect the flux, any variation in the flux
must propagate through each of the metabolites [37]. This results
in a uniform correlation structure among the metabolites, which in
turn yields weak causal linkages and order ambiguity among
metabolite nodes in the graphical model. However, graphical
models strongly and consistently associate metabolites to the QTL
node controlling their downstream flux in linear pathways
(Figure 3A, Text S1). The branching pathway is a linear pathway
with a sink that represents demand on a metabolite from another
reaction or pathway (Figure 2D). The stoichiometry of the
branching pathway was captured exactly with the graphical model
(Figure 3D). This suggests that the diversion of flux through side
reactions is helpful in defining pathway order. For merging
pathways, the correlation structure is dependent on the nature of
the reaction at the merge point. When two pathways merge
through a bi-substrate reaction (Figure 2B) there is strong
association between the substrates that combine, but these are
only weakly coupled to the downstream component of the
pathway. On the other hand, when two pathways merge through
independent reactions, the upstream metabolites A and B are only
weakly correlated with each other, but the there is strong uniform
correlation across the two linear components of the pathway
(Figure 3C). Ordering metabolites in the independent merging
pathway suffers from the same weaknesses as in the linear
pathway. These results emphasize the influence of network
stoichiometry on the correlation structure of the pathway.
Biosynthetic pathways, which often branch to produce two or
more end products, are especially prone to inhibition [38]. We
examined biosynthetic pathways that were inhibited in two ways:
(1) loss of function in one pathway branch and (2) substrate
inhibition. In the plant data, loss of function in AOP2 gave rise to
an epistatic interaction between loci on Chr 4 and Chr 5 [28,29].
Ignoring epistatic interactions and model fitting with only main-
effect terms led to dense graphs that were difficult to interpret
(data not shown). Substrate inhibition is estimated to occur in
approximately 20% of enzymes [39]. This process can be viewed
as a regulatory mechanism in which accumulation of a substrate
represses the reaction velocity. In our simulation, the accumula-
tion of metabolite D inhibits the flux through a branched pathway
(Figure 2E). The inhibition is reflected in the correlation structure,
D is negatively correlated with the other metabolites (Figure 3E).
QTL y2 disappears, suggesting that substrate inhibition can
dominate the effects of genetic perturbations (Figure 3D–E). The
correlation structure of this pathway was most sensitive to
conditioning on QTL. When substrate inhibition is present, a loss
of correlation and genetic control can occur, which makes two
connected pathways look independent. These results highlight the
importance of an accurate genetic model for network inference,
especially in the presence of inhibition and epistasis.
Estimation of kinetic parameters in dynamic models requires
time course data, which is often sparse, and the computations
involved can be challenging [40]. The choice of experimental
perturbations and design have been shown to have major
influence on parameter estimation, and subsequently the accuracy
of the computational model [41]. Complex models of biological
systems exhibit parameter sensitivities that span several orders of
magnitude [42]. Concentration profiles and model outputs are
sensitive to small changes in kinetic rate parameters [43,44]. The
impact of parameter values on concentrations carries over into the
correlation structure, and consequently, the downstream network
inference. In our simulations, the perturbation is analogous to
genetically determined non-competitive inhibition, where Vmax is
genetically perturbed to be either high or low, thereby changing the
flux capacity [45]. This strategy ensures that there is a significant
difference between genotype groups and enables us to identify
QTL. Random stochastic fluctuations were used as input and
propagated through the pathway. Stochastic inputs allow us to
examine the out of equilibrium dynamics of the system. The
fluctuations themselves represent some of the randomness the
pathway encounters from being part of a cellular system that is
continuously changing [46,47]. The models represent continuous
excitation of the cell with the assumption that the intra-cellular
Figure 7. Residual propagation. A real data illustration of the necessity of non-genetic residual propagation for causal inference. Consider the
causal model: Q?MT4?MSO4, where Q denotes the QTL on Chrs 4, 5 and their interaction. Comparison of MT4DQ and MSO4 shows correlation
suggesting a causal reaction. If the residual variation did not propagate (M~SO4) then MT4DQ and M~SO4 are approximately independent.
doi:10.1371/journal.pcbi.1002458.g007
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dynamics can be faithfully modeled with ODEs. Examining system
behavior over a spectrum of parameter values and stochastic
inputs would offer additional insight into the sensitivity of the
correlation structure.
Using both real data and simulated data, we tested the ability of
graphical models to capture causal relationships between variables
from from a variety of metabolic pathway topologies and
conditions. We found that the use of linear statistical models to
approximate relationships in dynamic non-linear systems from
static data has some merit, but the results should be interpreted
carefully. It is not realistic to expect to fully recover ordered
pathway relationships with causal inference methods. Our results
emphasize the necessity of biological variation beyond the genetic
factors in the model for reliable network inference. We
demonstrated that residual correlation induced between substrate
and product in a metabolic reaction can be dominated by variety
of factors, including, flux shunting, co-regulation, position in the
pathway, genetic factors and inhibition. We found that inhibition
can lead to missing edges in graphical models, washing out the
genetic signal and making connected pathways look independent.
An accurate genetic model is important, especially when epistasis
is present. Taken together, these results temper our expectations
and explain some of the success and failures of causal graphical
models for genotype-phenotype inference.
Materials and Methods
Arabidopsis Bay|Sha RIL
Metabolic QTL data from a population of 403 Arabidopsis
Bay|Sha recombinant inbred lines (RIL) were examined in this
study [28]. The data include measurements of 9 aliphatic
metabolites and genotypes from 38 markers across the genome.
A substantial number of samples have metabolite levels that are
below the level of detection (Table S1). We applied a
transformation to the scale log10(xz1). QTL mapping was
performed for each metabolite with R/qtl [48]. Genome scans for
single-QTL and two-QTL models were performed with Haley-
Knot regression. The logarithm of odds (LOD) threshold for
significance (Pv0:05) was calculated from 10,000 permutations
[49].
Simulating Deterministic Pathway Models
Pathway motifs were used to define systems of ODEs that
depend on flux rates, w, modeled with Michaelis-Menten kinetics
(Figure 2) [22]. If a substrate A produces B, then the rate of
reaction w : A?B is described by:
w~Vmax
A
KmzA
,
where Vmax is the maximum rate of velocity and Km is substrate
concentration at which half of Vmax is attained. When two
substrates A and B combine to produce C, w : AzB?C, we
write:
w~Vmax
A:B
KmzA:B
:
When the accumulation of a metabolite feeds-back to inhibit a
flux:
w~Vmax
A
KmzA(1zA=Ki)
,
where Ki is an affinity constant. This flux form represents substrate
inhibition which occurs at high substrate concentrations. As Ki??,
the reaction flux is uninhibited and approaches standard Michalis-
Menton form.
The dynamics of a substrate Ci is described with the mass
balance equations:
dCi
dt
~
Xn
k~1
yk(gk)wk{
Xm
j~nz1
yj(gj)wj ,
where wk : Cj?Ci and wj : Ci?Cj denote the production and
utilization of Ci respectively, the stoichiometric coefficients are given
as yk(gk) and yj(gj) and g is the genotype. Genetic perturbations
are made through the y coefficients as either high or low, depending
on the genotype AA or BB. For simplicity, we assume that each y
participates in a single reaction and that they are unlinked. In our
simulations, we set Vmax,Km~1,Ki~50, y(g~AA)~0:2 and
y(g~BB)~1:8. We also modeled a loss of function mutation by
setting y~0 for certain genotypes (Figure S3) [50].
There are 2n genotype combinations for each pathway of n
reactions. Each combination can be viewed as a sample from a
randomized genetic population. For every unique genotype
combination, we use an input flux that is perturbed by a random
process, j(t), modeled as a Brownian path over the interval ½0,tf 
[51]. The system is propagated, t~½0,tf~100. The perturba-
tions, Y [ Rn, and the concentration levels at the end of the
simulation C(tf ) [ Rn are collected as data for correlation analysis
and graphical model fitting. The output of each simulation can be
viewed a sample in mQTL data. A schematic depicting the entire
simulation process is shown in Figure S1.
Correlation Analysis and Causal Network Inference
The Pearson correlation is calculated for the variables in each
pathway architecture. Residuals are estimated after each metabolite
is conditioned on the QTL in the model. The residuals are used to
calculate the conditional correlation of the metabolites given the
genetic factors in the model. Directed graphical models are estimated
using Bayesian Networks with a MCMC algorithm [14]. In
pathways with epistasis, we include single degree of freedom
variables that represent a composite genotype as variables for
inference [52]. The sparsity parameter t was set in the range
0:1ƒtƒ0:5. Each chain was run from two starting points,
convergence was verified using correlation of edge weights (posterior
probabilities) and the acceptance rate of each chain was in the range
of 23%–45%. The results are based on the marginal summary over
the ten graphs with the highest posterior probability. Alternative
representations over the top 10,25 and 100 graphs and the four most
probable graphs for each pathway are presented in Text S1.
Supporting Information
Figure S1 A schematic of the simulation process. (1) A
mathematical model is constructed and described by ODEs, (2)
The system is genetically perturbed and propogated. The output
of the simulation serves as data for graphical model construction.
(3) The correlation structure is observed and graphical models are
constructed. The resulting correlation and inferred network is
compared to the metabolic pathway.
(TIF)
Figure S2 Simulated branching pathway with epistasis.
The signal S interacts with an enzyme y3 which causes a loss of
function for certain genotype combinations.
(TIFF)
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Figure S3 Chr4:Chr5 interaction plots. Interaction plots
are shown for each phenotype in the aliphatic glucosinolate
pathway.
(TIFF)
Table S1 Aliphatic metabolites. Abbreviations and the
number of lines that had measurements below detection level
are indicated. Non-detection may be due to biological or technical
reasons.
(PDF)
Table S2 Summary of single-locus genome scans for
aliphatic glucosinolates. The chromosome, position, locus,
LOD score and peak marker are indicated for each QTL. A
significance level of LOD= 2:24 (Pv0:05) was calculated from
10,000 permutations.
(PDF)
Table S3 Summary of two-locus genome scans for
aliphatic glucosinolates. Summary of two-locus genome scans
for the metabolites measured in the Bay6Sha RIL panel. Two
dimensional genome scans were performed to identify significant
interactions. For each pair of chromosomes, the following LOD
scores are calculated. lod.full: The difference in the maximum
LOD score for the full model (two main effect terms and
interaction) and the maximum LOD score for the additive model
(main effect terms only). lod.fv1: The difference in the maximum
LOD score for the full model and the maximum LOD score for
the LOD score from a single-QTL mapping of the two
chromosomes. lod.add: The maximum additive LOD score.
lod.av1: The difference between the maximum additive LOD
score and the maximum LOD score from a single-QTL mapping
of the two chromosomes. The positions for the full and additive
models (pos.f and pos.a respectively) are indicated. Significance
thresholds were set at the R/qtl suggested values for a backcross.
(PDF)
Text S1 Graphical models were reconstructed using a
MCMC algorithm. The result is an ensemble of graphs, each
with a posterior probability. Here we present different summari-
zations of the Bay6Sha reconstructed networks based on model
selection and marginal summaries over the most probable graphs.
(PDF)
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